[Prophylactic administration of Bactrim in chronic bronchitis. A double blind clinical and biological study (author's transl)].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000874:Anthracosilicosis / Q000150:complications; D001249:Asthma / Q000150:complications; D001424:Bacterial Infections / Q000150:complications / Q000517:prevention & control*; D001987:Bronchiectasis / Q000150:complications; D001991:Bronchitis / Q000150:complications; D002986:Clinical Trials as Topic; D003707:Demeclocycline / Q000009:adverse effects / Q000627:therapeutic use; D004341:Drug Evaluation; D004357:Drug Synergism; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011656:Pulmonary Emphysema / Q000150:complications; D013420:Sulfamethoxazole / Q000009:adverse effects / Q000627:therapeutic use*; D014295:Trimethoprim / Q000009:adverse effects / Q000627:therapeutic use*
D003707:Demeclocycline; D014295:Trimethoprim; D013420:Sulfamethoxazole
Administration à titre prophylactique du Bactrim dans la bronchite chronique. Etude clinique et biologique à double insu